Sorafenib extends the survival time of patients with multiple recurrences of hepatocellular carcinoma after liver transplantation (Q37729145)

From Wikidata
Jump to navigation Jump to search
scientific article published on November 22, 2010
edit
Language Label Description Also known as
English
Sorafenib extends the survival time of patients with multiple recurrences of hepatocellular carcinoma after liver transplantation
scientific article published on November 22, 2010

    Statements

    Sorafenib extends the survival time of patients with multiple recurrences of hepatocellular carcinoma after liver transplantation (English)
    Xiao-qing JIANG

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit